Pilot simplification study to Lopinavir/ritonavir 800/200 mg monotherapy regimen once daily [Estudio PILOTO de simplificación a una pauta de Lopinavir/ritonavir 800/200 mg en monoterapia una vez al día].

Trial Profile

Pilot simplification study to Lopinavir/ritonavir 800/200 mg monotherapy regimen once daily [Estudio PILOTO de simplificación a una pauta de Lopinavir/ritonavir 800/200 mg en monoterapia una vez al día].

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Oct 2016

At a glance

  • Drugs Lopinavir/ritonavir (Primary)
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Acronyms KMON
  • Most Recent Events

    • 14 Dec 2015 Status changed from recruiting to completed as results published in the Antiviral Therapy.
    • 14 Dec 2015 Results published in the Antiviral Therapy
    • 24 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top